Natco’s AP formulations unit gets USFDA Form 483 with 4 observations | Hyderabad News
Hyderabad: Natco Pharma Limited’s finished dosage formulations manufacturing facility at Parawada in Visakhapatnam, Andhra Pradesh, has received Form 483 with four observations from the United States Food and Drug Administration (USFDA).The Form 483 was issued after an inspection of the facility conducted from August 17 to August 21, 2026, by the US drug watchdog. A…
